Plain-English translation of NCT05894694 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether Compound Kushen Injection, a Chinese herbal medicine, can help people with advanced colorectal cancer live longer when used alongside standard chemotherapy. Half of the participants will receive standard chemotherapy alone, and the other half will receive the same chemotherapy plus the herbal injection. Researchers want to see if adding this medication improves survival and delays cancer growth.
Standard chemotherapy helps many people with advanced colorectal cancer, but doctors are looking for ways to improve outcomes further. This trial explores whether this traditional herbal medicine, combined with modern chemotherapy, might help patients live longer or keep their cancer from progressing as quickly.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either standard chemotherapy alone or standard chemotherapy plus Compound Kushen Injection. The herbal injection will be given alongside your regular chemotherapy treatments. You will have regular follow-up appointments and imaging scans to measure how well the treatment is working and to monitor how long you survive. The study will track your progress over time to compare outcomes between the two groups.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
China
Phase
Post-approval monitoring
Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Enrollment target
~320 participants
Started
September 2023
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in December 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
jie Li
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.